Why Onconova Therapeutic's Is Surging Today

Onconova Therapeutics, Inc. ONTX shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and $4 price target.

Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel products to treat cancer.

The company's stock was trading 45.6% higher at $0.89 per share on Tuesday at the time of publication. The stock has a 52-week high of $1.93 and a 52-week low of $0.19.